In non-small cell lung cancer (NSCLC), Shh pathway is activated, and immunohistochemistry (IHC) studies have shown an homogenous over-expression of Shh pathway proteins in NSCLC samples, with a good correlation between each protein, suggesting a canonical activation of Shh pathway [63]. This evidence concerns the gene SHH and non-small cell lung carcinoma.